Questions

Selank, answered

Direct answers to the questions people actually ask — pulled from the published research and cited where the claim is quantitative.

Is Selank a nootropic?

Yes, in the research sense. Selank had an optimizing action on a conditioned active-avoidance reflex in rats, a standard learning task, consistent with a nootropic, learning-supportive effect [8], and it experimentally improved learning and memory processes [9]. Its center of gravity, though, is anxiety relief, with the nootropic effects often tied to that calming action.

Does Selank increase BDNF in the hippocampus?

Yes, in rats. Intranasal administration of Selank regulated (increased) BDNF expression in the hippocampus of rats in vivo [3]. BDNF is a growth factor supporting neuron survival and plasticity, so this finding links Selank to neurotrophic signaling and offers a plausible mechanism for its reported mental clarity. This is rodent data, not a human-proven effect.

How long does Selank take to work?

There is no validated human onset time, so this draws on user reports and mechanism. People using the intranasal route commonly describe noticing a shift within roughly 20 to 40 minutes, which is anecdotal and varies between individuals. In research, Selank showed rapid behavioral effects in learning tasks in rats [8], but reported onset in people is not from controlled trials.

What is Selank?

Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro), a stabilized analogue of the endogenous immune peptide tuftsin, studied as an anxiolytic and nootropic. Its anxiolytic activity centers on positive allosteric modulation of GABA receptor binding, a subtype-selective, concentration-dependent mechanism that differs from benzodiazepines [1]. It was developed in Russia and is not FDA-approved.

What does Selank do?

In research, Selank reduces anxiety without the sedation of benzodiazepines, acting as a positive allosteric modulator of GABA receptor binding [1] while also inhibiting enkephalin-degrading enzymes [2]. It additionally raises hippocampal BDNF [3] and shows immunomodulatory effects [5]. The combined picture is a calming peptide with secondary nootropic and immune activity — studied mostly in rats and small Russian trials.

What is Selank peptide used for?

In the research literature, the Selank peptide is studied mainly for anxiety, where it acts as a positive allosteric modulator of GABA receptor binding distinct from benzodiazepines [1], and secondarily for learning and memory [8] and immune modulation [5]. It is not FDA-approved for any use and is sold only as a research chemical, so it has no approved therapeutic indication outside Russia.

How does Selank work?

Selank works through several routes at once. Its core anxiolytic mechanism is positive allosteric modulation of GABA receptor binding — tuning up the brain's main calming system from a side site — in a subtype-selective, concentration-dependent way that differs from benzodiazepines [1]. It also inhibits enkephalin-degrading enzymes [2], raises BDNF [3], and shifts monoamine and immune signaling [18][5].

Does Selank affect GABA receptors?

Yes — this is its central mechanism. Selank acts as a positive allosteric modulator of GABA receptor binding, with subtype-selective, concentration-dependent modulation, and it can block the modulatory activity of diazepam and olanzapine, indicating distinct but overlapping binding sites [1]. In rats it also shifted the expression of dozens of GABA-pathway genes, correlating with GABA's own effect [4].

What is Selank used for in research?

Research uses Selank to study anxiety, learning and memory, and immune modulation. In patients with anxiety-asthenic disorders it altered the Th1/Th2 cytokine balance and modulated IL-6, characterizing it as an immunomodulator alongside its anxiolytic action [5]. In animals it is used in anxiety models, learning paradigms, and stress-physiology studies. It is a research compound, not an approved treatment.

What is the difference between Selank and Semax?

They are different peptides with different parent molecules and primary roles. Selank is a tuftsin-analogue heptapeptide studied mainly as an anxiolytic, acting on GABA and enkephalinase systems [1][2]. Semax is a separate ACTH-derived peptide studied mainly as a nootropic and neuroprotective agent. They are often paired but should never be conflated; see the full breakdown on the Selank vs Semax page.

How does Selank differ from benzodiazepines for anxiety?

Selank modulates GABA receptor binding allosterically in a subtype-selective, concentration-dependent way distinct from benzodiazepines, and can even block their modulatory activity [1]. Clinically, Russian studies in generalized anxiety disorder reported an anxiolytic effect comparable to a benzodiazepine comparator but without the sedation, cognitive impairment, or withdrawal [6]. It also adds a non-GABA route via enkephalinase inhibition [2].

Is Selank addictive or does it cause withdrawal?

Russian clinical studies in generalized anxiety disorder reported an anxiolytic effect without the dependence or withdrawal seen with benzodiazepines [6], and the user community broadly echoes no tolerance escalation or rebound anxiety. Both signals are reassuring but rest on short-term, single-region, and partly anecdotal experience, not long human safety trials, so the long-term picture is not established.

Does Selank affect gene expression?

Yes, in rats. A single 300 µg/kg dose of Selank changed the expression of 45 genes involved in GABAergic neurotransmission at one hour and 22 genes at three hours, with the shifts correlating positively with the changes produced by GABA itself [4]. This connects Selank's anxiolytic action to measurable downstream changes in the GABA system.

Does Selank help with memory and focus?

In research, yes for memory in animal models; focus is mostly a user report. Selank optimized learning and memory tasks in rats [8][9] and raised hippocampal BDNF, a plasticity-linked growth factor [3]. The "calm but sharp" focus people describe is anecdotal and may stem from the anxiety relief rather than a direct stimulant effect. These are not human cognitive-performance trials.

Does Selank affect serotonin and dopamine?

Yes, in animals. Selank altered the content of serotonin, dopamine, and their metabolites in mouse brain in a strain-dependent manner [18], and it was used to correct measures of integrative brain activity and biogenic amine levels in rats [12]. This monoaminergic activity is one of several systems Selank touches alongside its core GABAergic mechanism.

How does Selank modulate the immune system?

As a tuftsin analogue, Selank carries immune activity. In patients with anxiety-asthenic disorders it shifted the Th1/Th2 cytokine balance and modulated peripheral-blood IL-6 expression, leading researchers to call it a novel immunomodulator [5]. It also influenced cytokine levels under stress in rats [19] and showed antiviral activity in experimental influenza in mice [20].

How does Selank affect cytokine levels under stress?

Selank modulated stress-induced cytokine levels in rats [19], and in patients with anxiety-asthenic disorders it shifted the Th1/Th2 cytokine balance and modulated IL-6 [5]. This immunomodulatory activity under stress load is consistent with its origin as an analogue of tuftsin, an endogenous immune peptide, and is part of what distinguishes it from conventional anxiolytics.

Has Selank been studied for alcohol or opioid withdrawal?

The cited literature on this site does not document Selank trials specifically for alcohol or opioid withdrawal. What it does show is GABAergic and opioid-system activity — positive allosteric GABA modulation [1] and enkephalinase inhibition [2] — plus a rat finding that Selank plus diazepam most effectively reduced stress-induced anxiety [7]. Those are mechanistic and anxiety-model findings, not withdrawal-treatment evidence.

Is Selank FDA approved?

No. Selank is not approved by the FDA or EMA for any indication. Its regulatory registration as an anxiolytic exists essentially only in Russia, where intranasal Selank was studied and registered [6]. In the United States it is sold strictly as a research chemical and is not intended for human use.

Is Selank legal in the United States?

Selank is not an approved drug in the United States and is not a controlled substance by name; it is sold only as a research chemical, not as a product for human use. It is not FDA-approved for any use [5]. Because it is unapproved, it cannot be marketed as a treatment, and its sourcing is unregulated, so purity and identity vary by supplier.

Does Selank have effects on the gut or stomach?

Yes, in rats. The synthetic anxiolytic Selank affected gastric wall blood flow and supported gastric mucosal protection [13], and Selank with its metabolites maintained homeostasis in the gastric mucosa [14]. It also altered stress-induced changes in colon microbiota composition [15]. These are rodent physiology findings, part of Selank's broad multi-system profile, not human gastrointestinal claims.

Should Semax and Selank be taken together in research?

The published Selank literature does not establish a validated Selank-plus-Semax protocol; the citable data cover each peptide separately. The one combination finding in Selank's record involves diazepam, not Semax — a rat study where Selank plus diazepam most reduced stress-induced anxiety [7]. Russian clinical work supports intranasal Selank as an anxiolytic on its own [6]. This site makes no usage or stacking recommendation.